IRS1 and polycystic ovary syndrome: MicroRNA-145 (miR-145) mimics inhibit the activation of p38 MAPK and extracellular signal-regulated kinase through targeting insulin receptor substrate 1 (IRS1), and overexpressed IRS1 abrogated this suppressive effect in the GCs derived from PCOS patients (Cai et al., 2017).